SRP19
Signal recognition particle 19 kDa protein
Also known as: SRP19_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09132
- Gene
- SRP19
- Ensembl
- ENSG00000153037
- Chromosome
- 5
- Canonical length
- 144 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nuclear bodies,Cytosol
OverviewNCBI Gene
Enables 7S RNA binding activity. Contributes to ribosome binding activity. Predicted to be involved in SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition. Located in cytosol; nuclear body; and nucleolus. Part of signal recognition particle, endoplasmic reticulum targeting. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
144 residues, UniProt reviewed canonical sequence.
>P09132|SRP19
1 MACAAARSPA DQDRFICIYP AYLNNKKTIA EGRRIPISKA VENPTATEIQ DVCSAVGLNV
61 FLEKNKMYSR EWNRDVQYRG RVRVQLKQED GSLCLVQFPS RKSVMLYAAE MIPKLKTRTQ
121 KTGGADQSLQ QGEGSKKGKG KKKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRP19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 75 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 75 nTPM
- liver: 46 nTPM
- pancreas: 41 nTPM
- pituitary gland: 39 nTPM
- tonsil: 37 nTPM
- thyroid gland: 37 nTPM
Single-cell type
- late primary spermatocytes: 231 nCPM
- syncytiotrophoblasts: 185 nCPM
- esophageal apical cells: 181 nCPM
- extravillous trophoblasts: 167 nCPM
- epididymal principal cells: 155 nCPM
- esophageal suprabasal cells: 150 nCPM
Immune cell
- plasmacytoid DC: 87 nTPM
- T-reg: 72 nTPM
- basophil: 67 nTPM
- MAIT T-cell: 61 nTPM
- memory CD4 T-cell: 55 nTPM
- memory B-cell: 55 nTPM
Brain region
- hypothalamus: 28 nTPM
- cerebral cortex: 26 nTPM
- white matter: 25 nTPM
- midbrain: 23 nTPM
- hippocampal formation: 23 nTPM
- cerebellum: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SRP19.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 37 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- -1.64
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cotranslational protein targeting to membrane
- SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Signal recognition particle, SRP19 subunit
- Signal recognition particle, subunit SRP19-like superfamily
- SRP19 protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SRP19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRP19 as an antibody target. Whether an autoantibody or antibody against SRP19 could matter depends on whether native SRP19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRP19 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRP19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...